![]() Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | ![]() AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ||
Founding Date | Founding Date 1994 | Founding Date 2018 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more |
Employees | Employees 8174% decrease | Employees 188 | Employees 94,300 |
Valuation ($) | Valuation ($) 96.2 m | Valuation ($) 243.3 m | Valuation ($) 2.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) $114.2m (FY, 2025) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) |
Cost of goods | Cost of goods $1m (FY, 2025) | Cost of goods N/A | Cost of goods $4.9b (FY, 2025) |
Gross profit | Gross profit $113.2m (FY, 2025) | Gross profit N/A | Gross profit $54.2b (FY, 2025) |
Net income | Net income ($3.1m) (FY, 2025) | Net income ($274.4m) (FY, 2025) | Net income $10.2b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 171.1m | Total funding raised N/A | Total funding raised $ 1b |

Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View company
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company